Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

MSST0005

SILu™Prot VEGFA Vascular endothelial growth factor A human

recombinant, expressed in HEK 293 cells, SIL MS Protein Standard, 13C- and 15N-labeled

Synonym(s):

SILu™Prot Vascular endothelial growth factor A

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Size/SKUAvailabilityPrice
10 μg

Estimated to ship onOctober 05, 2026fromMILWAUKEE

$885.00

About This Item

NACRES:
NA.12
UNSPSC Code:
23201100
Form:
lyophilized powder
Assay:
≥95% (SDS-PAGE)
Biological source:
human
Recombinant:
expressed in HEK 293 cells

$885.00

Estimated to ship onOctober 05, 2026Details

​
Request a Custom Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

human

Quality Segment

recombinant

expressed in HEK 293 cells

assay

≥95% (SDS-PAGE)

form

lyophilized powder

technique(s)

mass spectrometry (MS): suitable, protein mass spectrometry: suitable

UniProt accession no.

storage temp.

−20°C

Gene Information

human ... VEGFA(7422)

General description

SILu™ Prot VEGF165 is a recombinant, stable isotope-labeled human VEGF165 which incorporates [13C6,15N4]−Arginine and [13C6, 15N2]−Lysine. Expressed in human 293 cells, it is designed to be used as an internal standard for bioanalysis of VEGF165 by mass-spectrometry.

Suggested Quantitative Analysis Parameters
(MRM settings provided for three suggested peptides)

Biochem/physiol Actions

VEGF165 belongs to the PDGF/VEGF growth factor family characterized by the presence of eight conserved cysteine residues and a cystine knot structure1. VEGF is secreted by the majority of tumor cells and initiates angiogenesis by activating endothelial cells of existing blood vessels and promoting their migration2.
VEGF has also been implicated in correlation with poor prognosis in breast cancer2. In addition, VEGF is released in rheumatoid arthritis in response to TNF-α, increasing endothelial permeability and stimulating angiogenesis (formation of capillaries)3,4.

Physical form

Supplied as a lyophilized powder containing phosphate buffered saline

Other Notes

APMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGC

Legal Information

This product is licensed under U.S. Patent No. 7,396,688 and foreign counterparts from E. I. du Pont de Nemours and Company. The purchase of this product conveys to the buyer the nontransferable right to use the purchased amount of the product for research and development only, including services for a third party for consideration. The buyer cannot sell or otherwise transfer this product, its components or materials made using this product or its components to a third party. Information about licenses for excluded uses is available from: E. I. du Pont de Nemours and Company; Attn: Associate Director, Commercial Development; DuPont Experimental Station E268; 200 Powdermill Rd.; Wilmington, DE 19803; 1-877-881-9787 (voice),1-302-695-1437 (fax), licensing@dupont.com.
SILu is a trademark of Sigma-Aldrich Co. LLC

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
MSST0006V7259V6627
SILu™Prot VEGFA Vascular endothelial growth factor A human recombinant, expressed in HEK 293 cells, SIL MS Protein Standard, 13C- and 15N-labeled

Sigma-Aldrich

MSST0005

SILu™Prot VEGFA Vascular endothelial growth factor A human

SILu™Lite VEGFA Vascular endothelial growth factor A human recombinant, expressed in HEK 293 cells, MS Protein Standard

Sigma-Aldrich

MSST0006

SILu™Lite VEGFA Vascular endothelial growth factor A human

Vascular Endothelial Growth Factor human VEGF, recombinant, expressed in E. coli, powder, suitable for cell culture

Sigma-Aldrich

V7259

Vascular Endothelial Growth Factor human

Anti-Vascular Endothelial Growth Factor antibody produced in goat IgG fraction of antiserum, lyophilized powder

Sigma-Aldrich

V6627

Anti-Vascular Endothelial Growth Factor antibody produced in goat

description

recombinant, expressed in HEK 293 cells, SIL MS Protein Standard, 13C- and 15N-labeled

description

recombinant, expressed in HEK 293 cells, MS Protein Standard

description

VEGF, recombinant, expressed in E. coli, powder, suitable for cell culture

description

IgG fraction of antiserum, lyophilized powder

recombinant

expressed in HEK 293 cells

recombinant

expressed in HEK 293 cells

recombinant

expressed in E. coli

recombinant

-

biological source

human

biological source

human

biological source

human

biological source

goat

technique(s)

mass spectrometry (MS): suitable

technique(s)

mass spectrometry (MS): suitable

technique(s)

cell culture | mammalian: suitable

technique(s)

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 5-15 μg/mL, western blot: 1-2 μg/mL, neutralization: suitable

assay

≥95% (SDS-PAGE)

assay

≥98% (SDS-PAGE)

assay

≥98% (SDS-PAGE)

assay

-

form

lyophilized powder

form

lyophilized powder

form

powder

form

lyophilized powder

Gene Information

human ... VEGFA(7422)

Gene Information

human ... VEGFA(7422)

Gene Information

human ... VEGFA(7422)

Gene Information

human ... VEGFA(7422)

Storage Class

11 - Combustible Solids

WGK

WGK 1

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Questions

Reviews

No rating value

Active Filters